Hoth Therapeutics
OverviewSuggest Edit
Hoth Therapeutics is a development stage biopharmaceutical company focused on targeted therapeutics for patients suffering from indications such as atopic dermatitis. The Company also develops the BioLexa Platform, a product candidate intended to prevent the symptom-triggering flare-ups before they occur.
| Type | Public | |
| HQ | New York, US | Map |
| Website | hoththerapeutics.com |
Recent NewsAll News
- Hoth Therapeutics Announces Positive Preclinical Data of WEG232 Treatment, Developed for Cancer Patients Suffering from Erlotinib-Induced Facial Dermatitis and Hair Loss
- Hoth Therapeutics Announces Positive Preliminary, Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease
- Hoth Therapeutics Inc. Announces Closing of Initial Public Offering
Hoth Therapeutics Office Locations
Hoth Therapeutics Financials and Metrics
Hoth Therapeutics Revenue
| USD | |
|---|---|
Net income (Q2, 2020) | (2.5m) |
EBIT (Q2, 2020) | (2.5m) |
Market capitalization (17-Sept-2020) | 32.4m |
Closing stock price (17-Sept-2020) | 2.4 |
Cash (30-Jun-2020) | 4.9m |
| USD | Q3, 2017 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|
Net Income | (1.7m) | (1.9m) | (829.4k) | (2.1m) | (3.8m) | (1.8m) | (4.3m) |
Depreciation and Amortization | 916.0 | 302.0 | 608.0 | 916.0 | 305.0 | 610.0 | |
Accounts Payable | 1.5k | (22.2k) | (71.7k) | 65.0k | (117.0k) | 113.7k | (104.5k) |
Cash From Operating Activities | (240.3k) | (1.6m) | (764.0k) | (1.8m) | (3.4m) | (1.6m) | (4.0m) |
Hoth Therapeutics Cybersecurity Score
Hoth Therapeutics Online and Social Media Presence
Hoth Therapeutics's Trends
Hoth Therapeutics News and Updates
Hoth Therapeutics Announces Positive Preclinical Data of WEG232 Treatment, Developed for Cancer Patients Suffering from Erlotinib-Induced Facial Dermatitis and Hair Loss
Hoth Therapeutics Announces Positive Preliminary, Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease
Hoth Therapeutics Inc. Announces Closing of Initial Public Offering
Hoth Therapeutics Blogs
Hoth Therapeutics Frequently Asked Questions
How many employees does Hoth Therapeutics have?
Hoth Therapeutics has 2 employees.
Who are Hoth Therapeutics competitors?
Competitors of Hoth Therapeutics include Synthorx, KiOmed Pharma and Veloxis Pharmaceuticals.
Where is Hoth Therapeutics headquarters?
Hoth Therapeutics headquarters is located at 1 Rockefeller Plaza, 10th Floor, New York.
Where are Hoth Therapeutics offices?
Hoth Therapeutics has an office in New York.
How many offices does Hoth Therapeutics have?
Hoth Therapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies